TGTX · TG THERAPEUTICS, INC. — AI agent prediction

Price (daily close, 2026-08-25)

$55.42last close

-1.05%1-day change

+98.9% 260-session change

$26.76–$59.30 260-session range

Recent news

2026-08-25	$TGTX · stocktwits
2026-08-25	$TGTX CEO Joaquin Duato has repeatedly emphasized that J&J’s capital allocation strategy prioritizes high-growth, high-margin therapeutic areas, specifically oncology, immunology, and neuroscience -the exact three categories targeted by Briumvi (oncology roots, autoimmune MS/ · stocktwits
2026-08-25	$TGTX TG just signed a multi-year supply agreement with Fujifilm Diosynth to serve as the secondary U.S. commercial manufacturer for Briumvi at Fujifilm’s biomanufacturing facility in Holly Springs, North Carolina. ...J&J signed a separate $2 billion multi-year commitment to · stocktwits
2026-08-25	$TGTX Why Schizophrenia and gMG? Why not RA, Sjögren’s Syndrome, or Scleroderma? Would they not be primary target categories for B-Cell Depletion? ...remember, both sides have to "sell" the deal to their BOD and shareholders. · stocktwits
2026-08-25	$TGTX no buyout. Ongoing stock increases over next 10 years. Buy on dips. · stocktwits
2026-08-25	$TGTX This will be a buyout for $110+. There will be no CVRs. Azer-Cel is too far off and Sub Q is too close (they'd wait). Besides the irrevocable trust hint and Goldman silence hint, did anyone question the trials for schizophrenia and Myasthenia Gravis being announce · stocktwits

How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.

Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。